Bone Marrow-Derived Mesenchymal Stem Cells Differentiate into Cancer-Associated Fibroblasts and Promote Tumor Growth in Renal Cell Carcinoma
Authors:
- Hiroyuki KitanoHKHiroyuki Kitano
- Ryo YugeRYRyo Yuge
- Hiroyuki ShikumaHSHiroyuki Shikuma
- Kazuma YukihiroKYKazuma Yukihiro
- Tomoya HatayamaTHTomoya Hatayama
- Yoshinori NakanoYNYoshinori Nakano
- Shinsaku TasakaSTShinsaku Tasaka
- Mai OkazakiMOMai Okazaki
- Naofumi NomuraNNNaofumi Nomura
- Ryo TasakaRTRyo Tasaka
- Kyosuke IwaneKIKyosuke Iwane
- Yuki KohadaYKYuki Kohada
Open Access
Abstract
Background: Tumor–stroma interactions play a critical role in renal cell carcinoma (RCC) progression. Cancer-associated fibroblasts (CAFs) are considered key components of the tumor microenvironment; however, their origin remains controversial. This study aimed to determine whether bone marrow-derived mesenchymal stem cells (MSCs) contribute to CAF-like stromal changes and RCC progression. Methods: An orthotopic xenograft mouse model was established using luciferase- and GFP-labeled Caki-1 cells. MSCs labeled with PKH26 were administered intravenously. Tumor growth was evaluated using an in vivo imaging system and tumor volume measurements. Immunohistochemical analyses were performed to assess MSC localization and α-smooth muscle actin (α-SMA) expression. In vitro proliferation and migration assays were conducted using direct and indirect co-culture systems. Results: The intravenous administration of MSCs significantly increased tumor growth and bioluminescence intensity in an orthotopic model. The tumor volumes were significantly larger in the MSC-treated versus control group. An immunofluorescence analysis demonstrated partial co-localization of PKH26-labeled MSCs with α-SMA-positive fibroblast-like cells, suggesting acquisition of CAF-like features. Direct co-culture with MSCs significantly enhanced RCC cell proliferation and migration in vitro, whereas culturing in conditioned medium alone did not produce similar effects. Conclusions: Exogenously administered bone marrow-derived MSCs may be recruited into RCC tissues and acquire CAF-like features through interactions with tumor cells. These findings suggest that stromal–tumor cell interactions within the tumor microenvironment may contribute to RCC progression and represent a potential therapeutic target.Keywords
Funding Information
- Japan Society for the Promotion of Science (16K20142)
- Japan Society for the Promotion of Science (25K12614)
This publication has 34 references indexed in Scilit:
- The role of cancer‐associated fibroblasts in the tumour microenvironment of urinary systemClinical and Translational Medicine, 2025
- Heterogeneity and function of cancer-associated fibroblasts in renal cell carcinomaJournal of the National Cancer Center, 2023
- European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 UpdateEuropean Urology, 2022
- CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenaseHepatology, 2021
- Combination therapy using molecular‐targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinomaCancer Medicine, 2017
- Mesenchymal stem cells enhance growth and metastasis of colon cancerInternational Journal of Cancer, 2010
- Cancer-related inflammationNature, 2008
- Fibroblasts in cancerNature Reviews Cancer, 2006
- Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblastsBiochemical and Biophysical Research Communications, 2005
- Retention of Multilineage Differentiation Potential of Mesenchymal Cells during Proliferation in Response to FGFBiochemical and Biophysical Research Communications, 2001